STOCK TITAN

TWST (NASDAQ: TWST) proposed resale of 7,205 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TWST Form 144 reports a proposed sale of 7,205 common shares tied to restricted stock vesting on 02/20/2026.

The filing also records prior sales by Emily M. Leproust of $74,138.99 for 2,255 shares on 12/08/2025, $55,462.38 for 1,605 shares on 12/22/2025, and $232,924.08 for 5,001 shares on 02/03/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies of a proposed resale of vested restricted shares by an affiliate.

Form 144 lists a proposed sale of 7,205 common shares associated with restricted stock vesting on 02/20/2026. The filing documents the mechanism as "Restricted Stock Vesting" and identifies the issuer as the source.

Prior reported dispositions by Emily M. Leproust are included with transaction dates 12/08/2025, 12/22/2025, and 02/03/2026, reflecting recent sale activity. Timing and exact sale methods for the proposed shares are not specified in the excerpt.

Small, disclosed resale size with recent insider sales noted; impact appears routine.

The filing shows a proposed resale of 7,205 shares and three prior sales totaling 8,861 shares by the same reporting person in the past three months. Dollar values are listed as $74,138.99, $55,462.38, and $232,924.08.

These figures are factual disclosures of trading activity; cash‑flow treatment and plan reserves are not described in the provided excerpt. Subsequent filings would show execution details if sales occur.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TWST Form 144 report?

The filing reports a proposed sale of 7,205 common shares tied to restricted stock vesting on 02/20/2026. It also lists prior sales by Emily M. Leproust executed in 12/2025 and 02/03/2026.

Who sold shares recently according to the TWST excerpt?

The excerpt lists sales by Emily M. Leproust: 2,255 shares on 12/08/2025, 1,605 shares on 12/22/2025, and 5,001 shares on 02/03/2026. Each sale includes the dollar amount reported.

What dollar amounts are shown for the recent TWST sales?

The filing shows proceeds of $74,138.99 for 2,255 shares, $55,462.38 for 1,605 shares, and $232,924.08 for 5,001 shares, tied to the dates in the excerpt.

Are the 7,205 shares being sold from new issuances or vested awards?

The excerpt identifies the 7,205 common shares as associated with "Restricted Stock Vesting" with the issuer listed as the source on 02/20/2026. Further execution details are not included in the provided text.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.99B
60.32M
Diagnostics & Research
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO